Crossmark

Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results

Crossref DOI link: https://doi.org/10.1007/s11102-021-01177-w

Published Online: 2021-08-04

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Labadzhyan, Artak

Nachtigall, L B

Fleseriu, M https://orcid.org/0000-0001-9284-6289
Gordon, M B

Molitch, M

Kennedy, L

Samson, S L https://orcid.org/0000-0002-8159-7093
Greenman, Y https://orcid.org/0000-0003-4923-488X
Biermasz, N https://orcid.org/0000-0001-5817-3594
Bolanowski, M https://orcid.org/0000-0002-2360-6596
Haviv, A

Ludlam, W

Patou, G

Strasburger, C J https://orcid.org/0000-0001-7905-7357
License Information

Text and Data Mining valid from 2021-08-04

Version of Record valid from 2021-08-04
More Information

Article History

First Online: 4 August 2021